中国·太阳成集团tyc122cc(股份)有限公司-搜狗百科

Investor Relations

Announcements

Year

2022

2022

Search

View / Download

2022 / 12 / 13

VOLUNTARY ANNOUNCEMENT - Enrollment in the China Randomized Controlled Clinical Study of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System Completed
View / Download

2022 / 12 / 05

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2022
View / Download

2022 / 11 / 03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2022
View / Download

2022 / 10 / 20

VOLUNTARY ANNOUNCEMENT - Admission of Innovative Medical Devices in respect of Aortic Arch Stent Graft System (Fenestration) into Special Examination and Approval Procedure
View / Download

2022 / 10 / 05

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2022
View / Download

2022 / 09 / 05

FDA Approved Investigator-initiated Pre-market Clinical Trial of LAmbre™ Plus LAA Closure System Obtained Medical Insurance Coverage in the US
View / Download

2022 / 09 / 02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022
View / Download

2022 / 08 / 30

INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
View / Download

2022 / 08 / 12

NOTICE OF BOARD MEETING
View / Download

2022 / 08 / 03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2022

14F, LifeTech Scientific Building, Keji 12th Road South, High-tech Industrial Park, Nanshan District, Shenzhen City, Guangdong Province, 518063, PRC

Tel：+86 755 86026250
Fax：+86 755 86026251

Last Updated

Legal Statement Privacy Policy

© 2008-2024 LifeTech Scientific Corporation All rights reserved.